Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients

Introduction: One major challenge to achieving optimal patient outcome in extracorporeal membrane oxygenation (ECMO) is the development of effective dosing strategies in this critically ill patient population. Suboptimal drug dosing impacts on patient outcome as patients on ECMO often require revers...

Full description

Bibliographic Details
Main Authors: Cheng, Vesa, Abdul-Aziz, Mohd Hafiz, Roberts, Jason A., Shekar, Kiran
Format: Article
Language:English
English
English
Published: Taylor & Francis 2019
Subjects:
Online Access:http://irep.iium.edu.my/72299/
http://irep.iium.edu.my/72299/
http://irep.iium.edu.my/72299/
http://irep.iium.edu.my/72299/1/72299_Overcoming%20barriers%20to%20optimal%20drug_article.pdf
http://irep.iium.edu.my/72299/2/72299_Overcoming%20barriers%20to%20optimal%20drug_wos.pdf
http://irep.iium.edu.my/72299/3/72299_Overcoming%20barriers%20to%20optimal%20drug_scopus.pdf
id iium-72299
recordtype eprints
spelling iium-722992019-11-17T18:37:55Z http://irep.iium.edu.my/72299/ Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients Cheng, Vesa Abdul-Aziz, Mohd Hafiz Roberts, Jason A. Shekar, Kiran RM Therapeutics. Pharmacology RM300 Drugs and their action RS Pharmacy and materia medica Introduction: One major challenge to achieving optimal patient outcome in extracorporeal membrane oxygenation (ECMO) is the development of effective dosing strategies in this critically ill patient population. Suboptimal drug dosing impacts on patient outcome as patients on ECMO often require reversal of the underlying pathology with effective pharmacotherapy in order to be liberated of the life-support device. Areas covered: This article provides a concise review of the effective use of antibiotics, analgesics, and sedative by characterizing the specific changes in PK secondary to the introduction of the ECMO support. We also discuss the barriers to achieving optimal pharmacotherapy in patients on ECMO and also the current and potential research that can be undertaken to address these clinical challenges. Expert opinion: Decreased bioavailability due to sequestration of drugs in the ECMO circuit and ECMO induced PK alterations are both significant barriers to optimal drug dosing. Evidence-based drug choices may minimize sequestration in the circuit and would enable safety and efficacy to be maintained. More work to characterize ECMO related pharmacodynamic alterations such as effects of ECMO on hepatic cytochrome system are still needed. Novel techniques to increase target site concentrations should also be explored. Taylor & Francis 2019-02-01 Article PeerReviewed application/pdf en http://irep.iium.edu.my/72299/1/72299_Overcoming%20barriers%20to%20optimal%20drug_article.pdf application/pdf en http://irep.iium.edu.my/72299/2/72299_Overcoming%20barriers%20to%20optimal%20drug_wos.pdf application/pdf en http://irep.iium.edu.my/72299/3/72299_Overcoming%20barriers%20to%20optimal%20drug_scopus.pdf Cheng, Vesa and Abdul-Aziz, Mohd Hafiz and Roberts, Jason A. and Shekar, Kiran (2019) Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients. Expert Opinion on Drug Metabolism and Toxicology, 15 (2). pp. 103-112. ISSN 1742-5255 https://www.tandfonline.com/doi/abs/10.1080/17425255.2019.1563596?journalCode=iemt20 10.1080/17425255.2019.1563596
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
English
English
topic RM Therapeutics. Pharmacology
RM300 Drugs and their action
RS Pharmacy and materia medica
spellingShingle RM Therapeutics. Pharmacology
RM300 Drugs and their action
RS Pharmacy and materia medica
Cheng, Vesa
Abdul-Aziz, Mohd Hafiz
Roberts, Jason A.
Shekar, Kiran
Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients
description Introduction: One major challenge to achieving optimal patient outcome in extracorporeal membrane oxygenation (ECMO) is the development of effective dosing strategies in this critically ill patient population. Suboptimal drug dosing impacts on patient outcome as patients on ECMO often require reversal of the underlying pathology with effective pharmacotherapy in order to be liberated of the life-support device. Areas covered: This article provides a concise review of the effective use of antibiotics, analgesics, and sedative by characterizing the specific changes in PK secondary to the introduction of the ECMO support. We also discuss the barriers to achieving optimal pharmacotherapy in patients on ECMO and also the current and potential research that can be undertaken to address these clinical challenges. Expert opinion: Decreased bioavailability due to sequestration of drugs in the ECMO circuit and ECMO induced PK alterations are both significant barriers to optimal drug dosing. Evidence-based drug choices may minimize sequestration in the circuit and would enable safety and efficacy to be maintained. More work to characterize ECMO related pharmacodynamic alterations such as effects of ECMO on hepatic cytochrome system are still needed. Novel techniques to increase target site concentrations should also be explored.
format Article
author Cheng, Vesa
Abdul-Aziz, Mohd Hafiz
Roberts, Jason A.
Shekar, Kiran
author_facet Cheng, Vesa
Abdul-Aziz, Mohd Hafiz
Roberts, Jason A.
Shekar, Kiran
author_sort Cheng, Vesa
title Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients
title_short Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients
title_full Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients
title_fullStr Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients
title_full_unstemmed Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients
title_sort overcoming barriers to optimal drug dosing during ecmo in critically ill adult patients
publisher Taylor & Francis
publishDate 2019
url http://irep.iium.edu.my/72299/
http://irep.iium.edu.my/72299/
http://irep.iium.edu.my/72299/
http://irep.iium.edu.my/72299/1/72299_Overcoming%20barriers%20to%20optimal%20drug_article.pdf
http://irep.iium.edu.my/72299/2/72299_Overcoming%20barriers%20to%20optimal%20drug_wos.pdf
http://irep.iium.edu.my/72299/3/72299_Overcoming%20barriers%20to%20optimal%20drug_scopus.pdf
first_indexed 2023-09-18T21:42:26Z
last_indexed 2023-09-18T21:42:26Z
_version_ 1777413229306183680